Finance

Lists
Q3 2026 earnings • released • EPS beat +26,60% • Revenue beat +3,54%
See results
CVSH34:BVMF
Cvs Health Corporation BDR
46,47 BRL
+5,23%
(+2,31) 1D
6-ноя., 16:56:00 GMT-3  ·   BRL
All symbols
SymbolPriceChange% Change
Generating top insights for CVSH34...
Open
44,60 BRL
High
46,47 BRL
Low
44,36 BRL
Mkt. cap
107,13 млд
Avg. vol.
346,00
Volume
338,00
52-wk high
57,82 BRL
52-wk low
36,22 BRL
Shares outstanding
1,28 млд
No. of employees
260 миң
Open
44,60 BRL
High
46,47 BRL
Low
44,36 BRL
Mkt. cap
107,13 млд
Avg. vol.
346,00
Volume
338,00
52-wk high
57,82 BRL
52-wk low
36,22 BRL
Shares outstanding
1,28 млд
No. of employees
260 миң
News stories
From web sources and news partners
Profile
CVS Health Corporation is an American multinational healthcare company that owns CVS Pharmacy, a retail pharmacy chain; CVS Caremark, a pharmacy benefits manager; and Aetna, a health insurance provider, among many other brands. The company is the world's second largest healthcare company, behind UnitedHealth Group. In 2023, the company was ranked 64th in the Forbes Global 2000. CVS started in Lowell, Massachusetts by brothers Stanley and Sidney Goldstein and their partner Ralph Hoagland. The name stood for Consumer Value Stores. On November 4, 2026, CVS announced that they will split into two companies, making it the largest split in the healthcare business. Wikipedia
About Cvs Health Corporation BDR
CEODavid Joyner
Employees260 миң
Founded1963
HeadquartersВунсокет, Род Айленд, Америка Кошмо Штаттары
SectorHealth Care
IndustryHealth care provider
Last report
2026-ж., 4-ноя.
Fiscal period
Q3 2026
2,09 USD / 1,65 USD
+26,60%beat
Revenue / Est. (USD)
108,40 млд / 104,69 млд
+3,54%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
2026-ж. сен.
Revenue
105,10 млд
99,85 млд
105,46 млд
108,40 млд
Cost of goods sold
92,13 млд
84,80 млд
90,35 млд
93,50 млд
Cost of revenue
92,13 млд
84,80 млд
90,35 млд
93,50 млд
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
11,32 млд
10,93 млд
11,04 млд
11,33 млд
Operating expense
11,32 млд
10,93 млд
11,04 млд
11,33 млд
Total operating expenses
103,45 млд
95,73 млд
101,38 млд
104,83 млд
Operating income
1,65 млд
4,12 млд
4,07 млд
3,57 млд
Other non operating income
-88,00 млн
32,00 млн
31,00 млн
30,00 млн
EBT including unusual items
1,35 млд
3,94 млд
3,98 млд
2,85 млд
EBT excluding unusual items
1,37 млд
3,95 млд
3,99 млд
2,85 млд
Income tax expense
-1,57 млд
981,00 млн
982,00 млн
678,00 млн
Effective tax rate
-115,88%
24,91%
24,69%
23,80%
Other operating expenses
-
-
-
-
Net income
2,94 млд
2,94 млд
2,98 млд
2,17 млд
Net profit margin
2,80%
2,95%
2,82%
2,00%
Earnings per share
1,09
2,57
2,58
2,09
Interest and investment income
594,00 млн
574,00 млн
641,00 млн
-
Interest expense
-787,00 млн
-774,00 млн
-757,00 млн
-747,00 млн
Net interest expenses
-193,00 млн
-200,00 млн
-116,00 млн
-747,00 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
2,80 млд
5,23 млд
5,20 млд
4,70 млд
Gain or loss from assets sale
-
-
-
-
Upcoming events
AI content may include mistakes. Learn more
Google колдонмолору